Pathway analysis based on a genome-wide association study of polycystic ovary syndrome

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Shim, Unjin ^a   Kim, Han Na ^b   Lee, Hyejin ^b   Oh, Jee Young ^b   Sung, Yeon Ah ^b   Kim, Hyung Lae ^b  

^a Ewha Womans University   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; PHOSPHOLIPASE C BETA2; PHOSPHOLIPASE C BETA3; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY MASS; CCNE2 GENE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; FEMALE; GENE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GNAQ GENE; HUMAN; INS GENE; INSULIN RELEASE; MAJOR CLINICAL STUDY; MEIOSIS; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PLCB2 GENE; PLCB3 GENE; PLCZ1 GENE; PPP1CB GENE; PPP2R5A GENE; PPP2R5C GENE; PPP2R5D GENE; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMC3 GENE; SPDYA GENE; STXBP1 GENE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; META ANALYSIS (TOPIC); METABOLISM; SIGNAL TRANSDUCTION;

BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; META-ANALYSIS AS TOPIC; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION;

EID: 84943254286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136609     Document Type: Article

References (62)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004; 89 (6):2745-9. PMID: 15181052
2. Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update. 2009; 15(4):477-88. doi: 10.1093/humupd/dmp008 PMID: 19279045
3. Ehrmann DA, Kasza K, Azziz R, Legro RS, Ghazzi MN, Group PCTS. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90(1):66-71. PMID: 15507516
4. Legro RS, Driscoll D, Strauss JF III, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A. 1998; 95(25):14956-60. PMID: 9843997
5. Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab. 2006; 91(6):2100-4. PMID: 16219714
6. Franks S, Gharani N, McCarthy M. Candidate genes in polycystic ovary syndrome. Hum Reprod Update. 2001; 7(4):405-10.PMID: 11476353
7. Simoni M, Tempfer CB, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update. 2008; 14(5):459-84. doi: 10.1093/humupd/dmn024 PMID: 18603647
8. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet. 2005; 6(2):95-108. PMID: 15716906
9. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005; 37(11):1217-23. PMID: 16244653
10. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011; 43 (1):55-9. doi: 10.1038/ng.732 PMID: 21151128
11. Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012; 44(9):1020-5. doi: 10.1038/ng.2384 PMID: 22885925
12. Zhang L, Guo L, Peng Y, Chen B. Expression of T-STAR gene is associated with regulation of telomerase activity in human colon cancer cell line HCT-116. World J Gastroenterol. 2006; 12(25):4056-60. PMID: 16810759
13. Lee H, Oh JY, Sung YA, Chung H, Kim HL, Kim GS, et al. Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome. Hum Reprod. 2015; 30(3):723-31. doi: 10.1093/humrep/deu352 PMID: 25574032
14. Stringer S, Wray NR, Kahn RS, Derks EM. Underestimated effect sizes in GWAS: fundamental limitations of single SNP analysis for dichotomous phenotypes. PLoS One. 2011; 6(11):e27964. doi: 10.1371/journal.pone.0027964 PMID: 22140493
15. Cantor RM, Lange K, Sinsheimer JS. Prioritizing GWAS results: A review of statistical methods and recommendations for their application. Am J Hum Genet. 2010; 86(1):6-22. doi: 10.1016/j.ajhg.2009.11.017 PMID: 20074509
16. Wang K, Li M, Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat Rev Genet. 2010; 11(12):843-54. doi: 10.1038/nrg2884 PMID: 21085203
17. Ramanan VK, Shen L, Moore JH, Saykin AJ. Pathway analysis of genomic data: concepts, methods, and prospects for future development. Trends Genet. 2012; 28(7):323-32. doi: 10.1016/j.tig.2012.03.004 PMID: 22480918
18. Shahbaba B, Shachaf CM, Yu Z. A pathway analysis method for genome-wide association studies. Stat Med. 2012; 31(10):988-1000. doi: 10.1002/sim.4477 PMID: 22302470
19. Wang K, Zhang H, Kugathasan S, Annese V, Bradfield JP, Russell RK, et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet. 2009; 84 (3):399-405. doi: 10.1016/j.ajhg.2009.01.026 PMID: 19249008
20. Eleftherohorinou H, Wright V, Hoggart C, Hartikainen AL, Jarvelin MR, Balding D, et al. Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS One. 2009; 4(11):e8068. doi: 10.1371/journal.pone.0008068 PMID: 19956648
21. Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Boston: Blackwell Scientific; 1992.
22. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999; 84(10):3666-72. PMID: 10523012
23. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981; 140(7):815-30. PMID: 7258262
24. Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012; 18(2):146-70. doi: 10.1093/humupd/dmr042 PMID: 22064667
25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet. 2007; 81(3):559-75. PMID: 17701901
26. Segre AV, Consortium D, investigators M, Groop L, Mootha VK, Daly MJ, et al. Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet. 2010; 6(8).
27. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010; 42 (11):937-48. doi: 10.1038/ng.686 PMID: 20935630
28. Dumesic DA, Abbott DH. Implications of polycystic ovary syndrome on oocyte development. Semin Reprod Med. 2008; 26(1):53-61. doi: 10.1055/s-2007-992925 PMID: 18181083
29. Willis DS, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab. 1998; 83(11):3984-91. PMID: 9814480
30. Selway JL, Moore CE, Mistry R, John Challiss RA, Herbert TP. Molecular mechanisms of muscarinic acetylcholine receptor-stimulated increase in cytosolic free Ca(2+) concentration and ERK1/2 activation in the MIN6 pancreatic beta-cell line. Acta Diabetol. 2012; 49(4):277-89. doi: 10.1007/s00592-011-0314-9 PMID: 21833779
31. Lam TK, van de Werve G, Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab. 2003; 284(2):E281- 90. PMID: 12531742
32. Mohlig M, Weickert MO, Ghadamgadai E, Machlitt A, Pfuller B, Arafat AM, et al. Adipocyte fatty acidbinding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Eur J Endocrinol. 2007; 157 (2):195-200. PMID: 17656598
33. San Millan JL, Corton M, Villuendas G, Sancho J, Peral B, Escobar-Morreale HF. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab. 2004; 89(6):2640-6. PMID: 15181035
34. Liu M, Sun J, Cui J, Chen W, Guo H, Barbetti F, et al. INS-gene mutations: from genetics and beta cell biology to clinical disease. Mol Aspects Med. 2015; 42:3-18. doi: 10.1016/j.mam.2014.12.001 PMID: 25542748
35. Carmody D, Park SY, Ye H, Perrone ME, Alkorta-Aranburu G, Highland HM, et al. Continued lessons from the INS gene: an intronic mutation causing diabetes through a novel mechanism. J Med Genet. 2015.
36. Ferk P, Perme MP, Gersak K. Insulin gene polymorphism in women with polycystic ovary syndrome. J Int Med Res. 2008; 36(6):1180-7. PMID: 19094425
37. Skrgatic L, Baldani DP, Gersak K, Cerne JZ, Ferk P, Coric M. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women. Coll Antropol. 2013; 37(1):141-6. PMID: 23697264
38. Yun JH, Gu BH, Kang YB, Choi BC, Song S, Baek KH. Association between INS-VNTR polymorphism and polycystic ovary syndrome in a Korean population. Gynecol Endocrinol. 2012; 28(7):525-8. doi: 10.3109/09513590.2011.650658 PMID: 22468791
39. Wiltgen D, Spritzer PM. Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes. Fertil Steril. 2010; 94(6):2493-6. doi: 10.1016/j.fertnstert.2010.02.015 PMID: 20338557
40. Zhao Y, Qiao J. Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids. 2013; 78(8):755-60. doi: 10.1016/j.steroids.2013.04.006 PMID: 23624030
41. Klenke S, Tan S, Hahn S, Mann K, Hauner H, Manthey I, et al. A functional GNAQ promoter haplotype is associated with altered Gq expression and with insulin resistance and obesity in women with polycystic ovary syndrome. Pharmacogenet Genomics. 2010; 20(8):476-84. doi: 10.1097/FPC.0b013e32833b7497 PMID: 20562673
42. Spurlin BA, Park SY, Nevins AK, Kim JK, Thurmond DC. Syntaxin 4 transgenic mice exhibit enhanced insulin-mediated glucose uptake in skeletal muscle. Diabetes. 2004; 53(9):2223-31. PMID: 15331531
43. Zawalich WS, Bonnet-Eymard M, Zawalich KC. Signal transduction in pancreatic beta-cells: regulation of insulin secretion by information flow in the phospholipase C/protein kinase C pathway. Front Biosci. 1997; 2:d160-72. PMID: 9159224
44. Ortmann O, Tomic M, Weiss JM, Diedrich K, Stojilkovic SS. Dual action of androgen on calcium signaling and luteinizing hormone secretion in pituitary gonadotrophs. Cell Calcium. 1998; 24(3):223-31. PMID: 9883276
45. Tse FW, Tse A, Hille B, Horstmann H, Almers W. Local Ca2+ release from internal stores controls exocytosis in pituitary gonadotrophs. Neuron. 1997; 18(1):121-32. PMID: 9010210
46. Ha L, Shi Y, Zhao J, Li T, Chen ZJ. Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women. PLoS One. 2015; 10(5):e0126505. doi: 10.1371/journal.pone.0126505 PMID: 25978310
47. Chen RM, Zhang Y, Yang XH, Lin XQ. Analysis of a family affected with familial male-limited precocious puberty due to a Ala568Val mutation in LHCGR gene. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012; 29 (6):631-4. doi: 10.3760/cma.j.issn.1003-9406.2012.06.002 PMID: 23225038
48. Haouzi D, Assou S, Monzo C, Vincens C, Dechaud H, Hamamah S. Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome. Hum Reprod. 2012; 27(12):3523-30. doi: 10.1093/humrep/des325 PMID: 22951915
49. Nomikos M, Swann K, Lai FA. Starting a new life: sperm PLC-zeta mobilizes the Ca2+ signal that induces egg activation and embryo development: an essential phospholipase C with implications for male infertility. Bioessays. 2012; 34(2):126-34. doi: 10.1002/bies.201100127 PMID: 22086556
50. Amdani SN, Jones C, Coward K. Phospholipase C zeta (PLCzeta): oocyte activation and clinical links to male factor infertility. Adv Biol Regul. 2013; 53(3):292-308. doi: 10.1016/j.jbior.2013.07.005 PMID: 23916605
51. Ansari M, Poke G, Ferry Q, Williamson K, Aldridge R, Meynert AM, et al. Genetic heterogeneity in Cornelia de Lange syndrome (CdLS) and CdLS-like phenotypes with observed and predicted levels of mosaicism. J Med Genet. 2014; 51(10):659-68. doi: 10.1136/jmedgenet-2014-102573 PMID: 25125236
52. Gil-Rodriguez MC, Deardorff MA, Ansari M, Tan CA, Parenti I, Baquero-Montoya C, et al. De novo heterozygous mutations in SMC3 cause a range of Cornelia de Lange syndrome-overlapping phenotypes. Hum Mutat. 2015; 36(4):454-62. doi: 10.1002/humu.22761 PMID: 25655089
53. Cheng Q, Huang W, Chen N, Shang Y, Zhang H. SMC3 may play an important role in atopic asthma development. Clin Respir J. 2014.
54. Kon A, Shih LY, Minamino M, Sanada M, Shiraishi Y, Nagata Y, et al. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms. Nat Genet. 2013; 45(10):1232-7. doi: 10.1038/ng.2731 PMID: 23955599
55. Solomon DA, Kim JS, Waldman T. Cohesin gene mutations in tumorigenesis: from discovery to clinical significance. BMB Rep. 2014; 47(6):299-310.PMID: 24856830
56. Velusamy T, Palanisamy N, Kalyana-Sundaram S, Sahasrabuddhe AA, Maher CA, Robinson DR, et al. Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2013; 110(8):3035-40. doi: 10.1073/pnas.1214326110 PMID: 23382248
57. Chen D, Guo W, Qiu Z, Wang Q, Li Y, Liang L, et al. MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer. Cancer Lett. 2015; 362(2):208-17. doi: 10.1016/j.canlet.2015.03.041 PMID: 25843294
58. Li Z, Meng Q, Yu Q, Zhou Z, Li L. Evaluation of c-myc and CCNE2 amplification in breast cancer with quantitative multi-gene fluorescence in-situ hybridization. Zhonghua Bing Li Xue Za Zhi. 2014; 43 (7):455-8. PMID: 25327794
59. Loveday C, Tatton-Brown K, Clarke M, Westwood I, Renwick A, Ramsay E, et al. Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth. Hum Mol Genet. 2015.
60. Sontag JM, Sontag E. Protein phosphatase 2A dysfunction in Alzheimer's disease. Front Mol Neurosci. 2014; 7:16. doi: 10.3389/fnmol.2014.00016 PMID: 24653673
61. Yu UY, Yoo BC, Ahn JH. Regulatory B Subunits of Protein Phosphatase 2A Are Involved in Site-specific Regulation of Tau Protein Phosphorylation. Korean J Physiol Pharmacol. 2014; 18(2):155-61. doi: 10.4196/kjpp.2014.18.2.155 PMID: 24757378
62. Bassiouny YA, Rabie WA, Hassan AA, Darwish RK. Association of the luteinizing hormone/choriogonadotropin receptor gene polymorphism with polycystic ovary syndrome. Gynecol Endocrinol. 2014; 30 (6):428-30. doi: 10.3109/09513590.2014.895982 PMID: 24592983